|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Turning Point Therapeutics, Inc. (TPTX) |
|
|
$76.01 0.00 (0.00%) as of 4:30 Tue 8/16
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
19 |
|
|
|
Total
Direct Shares :
|
2,275,309 |
|
|
Total
Indirect Shares :
|
13,300,358 |
| |
%
Held by Insiders:
|
4.72% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Countouriotis Athena |
President & CEO, Director |
2022-08-17 |
0 |
2019-09-10 |
0 |
| Sun Brian |
SVP & General Counsel |
2022-08-17 |
0 |
2022-04-11 |
0 |
| Tombesi Paolo |
EVP & Chief Financial Officer |
2022-08-17 |
0 |
2021-07-26 |
0 |
| Hirmand Mohammad |
EVP and Chief Medical Officer |
2022-08-17 |
0 |
2021-01-04 |
0 |
| Alles Mark J |
Director |
2022-08-17 |
0 |
2021-06-21 |
0 |
| Sabus Steve M |
SVP & Chief Commercial Officer |
2022-08-17 |
0 |
2022-05-31 |
0 |
| Reich Siegfried |
EVP & Chief Scientific Officer |
2022-02-09 |
17,015 |
2021-02-08 |
0 |
| North Annette |
EVP & General Counsel |
2022-02-09 |
27,979 |
2021-02-01 |
0 |
| Partridge Andrew John |
EVP & Chief Commercial Officer |
2022-02-09 |
38,361 |
2020-07-13 |
0 |
| Baker Brian Lee |
SVP of Finance and Admin. |
2021-03-23 |
4,116 |
2019-04-22 |
0 |
| Larson Yi |
EVP & Chief Financial Officer |
2021-02-08 |
7,321 |
2019-09-10 |
0 |
| Cui Jingrong Jean |
Director |
2020-06-09 |
1,001,298 |
2020-06-09 |
840,383 |
| Chen Bihua |
Director, 10% Owner |
2019-05-14 |
0 |
2019-05-14 |
3,122,367 |
| Glaxosmithkline Plc |
Director |
2019-04-22 |
0 |
2020-05-21 |
2,253,660 |
| Lu Hongbo |
Director |
2019-04-22 |
0 |
2019-04-22 |
1,727,550 |
| Orbimed Capital Gp Vi Llc |
Director |
2019-04-22 |
0 |
2019-04-22 |
2,027,550 |
| Gordon Carl L |
Director |
2019-04-22 |
0 |
2019-04-22 |
2,027,550 |
| George Simeon |
Director |
2019-04-22 |
0 |
2022-08-17 |
0 |
| Li Yishan |
Director, 10% Owner |
2019-04-16 |
1,179,219 |
2019-04-16 |
1,301,298 |
|
|
